Clinical trials
Recruiting Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascentage Pharma Group Inc. | 1 |
| Enliven Therapeutics | 1 |
| Imperial College London | 1 |
| Novartis Pharmaceuticals | 1 |
| Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| University of Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myelodysplastic Syndromes | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Blast Crisis | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.